Results 1 to 10 of about 16,759 (220)
Dermoscopy of disorders of hypopigmentation
Pigment International, 2022 Dermoscopy has traditionally been used to diagnose neoplasms and, more recently, to evaluate inflammatory conditions. Recent observational studies have suggested a role for dermoscopy in identifying and differentiating various hypopigmentary disorders ...
Yasmeen Jabeen Bhat +2 more
doaj +4 more sources
Laser Treatment of Hypopigmentation in Scars: A Review [PDF]
Dermatologic Surgery, 2021 BACKGROUND Despite history of multiple treatment modalities, repigmentation of hypopigmented scars remains a difficult clinical problem. OBJECTIVE The purpose of this review is to evaluate the literature on laser and combination laser plus adjunct ...
Erica G. Baugh +2 more
openalex +2 more sources
Steroid-induced perilymphatic hypopigmentation: Response to tacrolimus
Pigment International, 2018 Intralesional steroids are commonly used in dermatological practice. This route of administration has the advantage of minimal side effects. However, other adverse reactions namely local atrophy, ulceration, infections, etc. have been noted. One peculiar
Sneha Ghunawat, Rashmi Sarkar
doaj +2 more sources
Hypopigmentation Induced by Frequent Low-Fluence, Large-Spot-Size QS Nd:YAG Laser Treatments [PDF]
Annals of Dermatology, 2015 The Q-switched 1064-nm neodymium-doped yttrium aluminum garnet (QS 1064-nm Nd:YAG) laser is increasingly used for nonablative skin rejuvenation or "laser toning" for melasma.
Yisheng Wong +2 more
openalex +2 more sources
Dermatologic Therapy, 2019 Intralesional steroid injection is a common and highly effective treatment procedure, which can be successfully used for several dermatologic, rheumatologic, and orthopedic disorders. However, it may be associated with various local side effects, such as
Francesca Magri +3 more
openalex +2 more sources
Beyond Epilepsy and Autism: Disruption of GABRB3 Causes Ocular Hypopigmentation
Cell Reports, 2016 Reduced ocular pigmentation is common in Angelman syndrome (AS) and Prader-Willi syndrome (PWS) and is long thought to be caused by OCA2 deletion. GABRB3 is located in the 15q11-13 region flanked by UBE3A, GABRA5, GABRG3, and OCA2.
Ryan J. Delahanty +9 more
doaj +2 more sources
Reversible hypopigmentation with pazopanib
Indian Journal of Medical and Paediatric Oncology, 2018 Tablet Pazopanib known to cause Hypo pigmentation and Hyperpigmentation as per various literature reports. We report here a case of reversible hypopigmentation with Pazopanib in a patient treated for spindle cell sarcoma.
B J Srinivasa +3 more
doaj +3 more sources
Natural Melanogenesis Stimulator a Potential Tool for the Treatment of Hypopigmentation Disease [PDF]
, 2017 Vitiligo is one of the most well-known conditions of skin depigmentation. It is estimated to occur in up to 2% of the world’s population. A number of people, these patches can prove all over the body.
Kamal Uddin Zaidi
openalex +2 more sources
Melanogenesis and hypopigmentation: The case of vitiligo
Indian Journal of Dermatology, 2022 Melanocytes are highly specialized dendritic cells that synthesize and store melanin in subcellular organelles called melanosomes, before transfer to keratinocytes.
M Pilar Vinardell +2 more
doaj +4 more sources